NCT06235671

Brief Summary

The primary aims of the proposed trial are centered around examining the feasibility of conducting a prospective, chiropractic intervention study on a population of cancer survivors living in and around Atlanta, Georgia. This includes evaluating various implementation outcomes including recruitment, adherence, tolerability, retention, acceptability, and data fidelity. The results of this trial will inform the design of a future randomized controlled trial (RCT) that has an increased focus on the efficacy/effectiveness of chiropractic care on chronic cancer-related fatigue (CCRF) and other cancer-related sequelae in cancer survivors.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable cancer

Timeline
Completed

Started Mar 2024

Shorter than P25 for not_applicable cancer

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 23, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

February 1, 2024

Completed
29 days until next milestone

Study Start

First participant enrolled

March 1, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2024

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

February 1, 2024

Status Verified

January 1, 2024

Enrollment Period

6 months

First QC Date

January 23, 2024

Last Update Submit

January 31, 2024

Conditions

Keywords

cancer survivorsupper cervical chiropracticmanipulationcancer-related fatigueautonomic nervous system

Outcome Measures

Primary Outcomes (9)

  • Participant recruitment

    Average number of participants recruited/enrolled per month

    6-month data collection period

  • Participant scheduling

    Average time lag between first lab assessment \& first chiropractic visit

    6-month data collection period

  • Participant compliance

    Proportion of participants violating 1 or more pre-assessment lifestyle restrictions \& unable/unwilling to be rescheduled

    6-month data collection period

  • Participant adherence

    Proportion of participants not attending at least 80% of their chiropractic sessions

    6-month data collection period

  • Participant tolerability

    Proportion of participants unable/unwilling to complete a given assessment

    6-month data collection period

  • Participant retention

    Proportion of participants completing the trial

    6-month data collection period

  • Assessment acceptability

    Most common patient-related acceptability score for each assessment process/procedure

    6-month data collection period

  • Data fidelity

    Proportion of acquisitions from a given assessment that are unsuitable for analysis

    6-month data collection period

  • Implementation acceptability

    Most common clinician-rated acceptability score for each trial process/procedure

    6-month data collection period

Study Arms (1)

Chiropractic intervention

EXPERIMENTAL

Upper cervical chiropractic care

Procedure: Chiropractic care

Interventions

6 weeks of chiropractic care

Chiropractic intervention

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Able to understand and provide written informed consent in English
  • years of age
  • Informed by primary health care provider that there is no evidence of active disease (this is sometimes referred to as "complete remission" or "cured")
  • Minimum of 3 months since completion of primary curative-intent cancer therapies including surgery, chemotherapy, radiotherapy, and/or immunotherapy (long-term hormonal therapy permitted)
  • Onset of fatigue occurred at some point during illness and/or treatment
  • FACIT-Fatigue scale score in the moderate-to-severe range (i.e., at or above the 60th percentile)
  • If on any prescription medication (including hormonal therapy), on a stable dose for a minimum of 12 weeks with no plans to change medications or doses during the study

You may not qualify if:

  • Taking any short-acting benzodiazepine including midazolam \& triazolam
  • Known disorder resulting in syncope/fainting during postural changes (e.g., postural orthostatic tachycardia syndrome, orthostatic hypotension)
  • Pacemaker or known heart condition that influences the electrical or mechanical function of the heart (e.g., severe heart valve disease)
  • Diagnosed with an externalizing (e.g., substance use, antisocial disorder) or thought (e.g., schizophrenia, paranoid personality, bipolar) disorder that is uncontrolled or untreated
  • Diagnosed with rheumatoid arthritis, osteoporosis, or cervical spine instability
  • Currently pregnant
  • Current litigation related to a physical, health-related injury
  • Chronic pain rated at least 3/10 on a visual analog scale (VAS)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dr. Sid E. Williams Center for Chiropractic Research

Atlanta, Georgia, 30308, United States

Location

MeSH Terms

Conditions

NeoplasmsFatigue

Condition Hierarchy (Ancestors)

Signs and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Yori Gidron, PhD

    University of Haifa

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Austin Garlinghouse

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Single-arm feasibility trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 23, 2024

First Posted

February 1, 2024

Study Start

March 1, 2024

Primary Completion

September 1, 2024

Study Completion

December 31, 2024

Last Updated

February 1, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share

Locations